van Leeuwen R - Search Results

1

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.

Reijers MH, Weverling GJ, Jurriaans S, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Frissen PH, van Leeuwen R, Reiss P, Schuitemaker H, de Wolf F, Lange JM. Reijers MH, et al. Among authors: van leeuwen r. Lancet. 1998 Jul 18;352(9123):185-90. doi: 10.1016/s0140-6736(98)06193-5. Lancet. 1998. PMID: 9683207 Clinical Trial.

2

Treatment of HIV infection. Tolerability of commonly used antiretroviral agents.

Notermans DW, van Leeuwen R, Lange JM. Notermans DW, et al. Among authors: van leeuwen r. Drug Saf. 1996 Sep;15(3):176-87. doi: 10.2165/00002018-199615030-00003. Drug Saf. 1996. PMID: 8879972 Review.

3

Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy.

Foudraine NA, Weverling GJ, van Gool T, Roos MT, de Wolf F, Koopmans PP, van den Broek PJ, Meenhorst PL, van Leeuwen R, Lange JM, Reiss P. Foudraine NA, et al. Among authors: van gool t, van den broek pj, van leeuwen r. AIDS. 1998 Jan 1;12(1):35-41. doi: 10.1097/00002030-199801000-00005. AIDS. 1998. PMID: 9456253 Clinical Trial.

4

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Wit FW, van Leeuwen R, Weverling GJ, Jurriaans S, Nauta K, Steingrover R, Schuijtemaker J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM. Wit FW, et al. Among authors: van leeuwen r. J Infect Dis. 1999 Apr;179(4):790-8. doi: 10.1086/314675. J Infect Dis. 1999. PMID: 10068573

5

A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.

Kroon ED, Ungsedhapand C, Ruxrungtham K, Chuenyam M, Ubolyam S, Newell ME, van Leeuwen R, Kunanusont C, Buranapraditkul S, Sirivichayakul S, Lange JM, Cooper DA, Phanuphak P. Kroon ED, et al. Among authors: van leeuwen r. AIDS. 2000 Jul 7;14(10):1349-56. doi: 10.1097/00002030-200007070-00007. AIDS. 2000. PMID: 10930149 Clinical Trial.

6

A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients.

Ruxrungtham K, Kroon ED, Ungsedhapand C, Teeratakulpisarn S, Ubolyam S, Buranapraditkun S, van Leeuwen R, Weverling GJ, Kunanusont C, Lange JM, Cooper DA, Phanuphak P. Ruxrungtham K, et al. Among authors: van leeuwen r. AIDS. 2000 Jul 7;14(10):1375-82. doi: 10.1097/00002030-200007070-00010. AIDS. 2000. PMID: 10930152 Clinical Trial.

7

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

den Brinker M, Wit FW, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R, Pakker NG, Reiss P, Danner SA, Weverling GJ, Lange JM. den Brinker M, et al. Among authors: van leeuwen r. AIDS. 2000 Dec 22;14(18):2895-902. doi: 10.1097/00002030-200012220-00011. AIDS. 2000. PMID: 11153671 Clinical Trial.

8

Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.

Wit FW, Wood R, Horban A, Beniowski M, Schmidt RE, Gray G, Lazzarin A, Lafeuillade A, Paes D, Carlier H, van Weert L, de Vries C, van Leeuwen R, Lange JM. Wit FW, et al. Among authors: van weert l, van leeuwen r. AIDS. 2001 Dec 7;15(18):2423-9. doi: 10.1097/00002030-200112070-00010. AIDS. 2001. PMID: 11740193 Clinical Trial.

9

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JM; 2NN Study team. van Leth F, et al. Among authors: van der westhuizen ip, van leeuwen r. Lancet. 2004 Apr 17;363(9417):1253-63. doi: 10.1016/S0140-6736(04)15997-7. Lancet. 2004. PMID: 15094269 Clinical Trial.

10

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.

Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A; NEAT001/ANRS143 Study Group. Raffi F, et al. Among authors: van leeuwen r. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4. Lancet. 2014. PMID: 25103176 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters